baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BioMarin Pharmaceutical/ US09061G1013 /

5/9/2025 9:59:58 PM	Chg. -0.99	Volume	Bid-	Ask-	Market Capitalization	Dividend Y.	P/E Ratio
58.84USD	-1.65%	52,174 Turnover: 3.1 mill.	-Bid Size: -	-Ask Size: -	11.29 bill.USD	-	26.16

GlobeNewswire 4/8 Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer

GlobeNewswire 7/26/2024 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...

GlobeNewswire 7/20/2024 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...

GlobeNewswire 7/12/2024 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...

GlobeNewswire 7/7/2024 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...

GlobeNewswire 6/30/2024 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharm...

GlobeNewswire 6/28/2024 Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease

GlobeNewswire 6/22/2024 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...

GlobeNewswire 6/13/2024 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...

GlobeNewswire 6/5/2024 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...

GlobeNewswire 5/28/2024 Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors

GlobeNewswire 5/8/2024 Terns Pharmaceuticals Announces Leadership Changes

GlobeNewswire 11/2/2023 California Life Sciences announces 20th annual Pantheon Award winners

GlobeNewswire 10/2/2023 California’s top scientific innovators selected as finalists for the 20th annual California Life Sci...

GlobeNewswire 3/1/2022 Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2021 Financial Results and Recent Corpor...

GlobeNewswire 2/14/2022 Vaxart Appoints Edward Berg as Senior Vice President and General Counsel

Newsfile Corp 2/4/2022 SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BioMarin Pharmaceutical Inc.

GlobeNewswire 1/24/2022 SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BioMarin Pharmaceutical Inc.

GlobeNewswire 12/23/2021 Lifshitz Law Firm, P.C. Announces Investigations of Amarin Corporation plc (NASDAQGM: AMRN), BioMari...

GlobeNewswire 12/21/2021 BMRN FINAL DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioMarin Pharmaceutical Inc....

GlobeNewswire 12/20/2021 BMRN & RECAF – Upcoming Lead Deadlines: Bronstein, Gewirtz & Grossman, LLC

GlobeNewswire 12/20/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...

GlobeNewswire 12/17/2021 ROSEN, A LEADING LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Losses to Secure C...

GlobeNewswire 12/7/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...

GlobeNewswire 12/7/2021 ROSEN, A LEADING LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors to Secure Counsel Befor...

BioMarin Pharmaceutical/ US09061G1013 /

If you wish to receive reply to your feedback, please provide your email address.